Abstract
Aims: To test the hypothesis that compared with placebo, concomitant treatment with nortriptyline or venlafaxine during the ECT course enhances short-term effi cacy without exerting a meaningful effect on adverse effects and reduces the rate of post-ECT relapse, and to test the hypothesis that high-dose RUL ECT is equivalent in effi cacy to moderatedose BL ECT and retains advantages with respect to adverse cognitive effects. This was a prospective, randomized, triplemasked, placebo-controlled study conducted from 2001 through 2005 in three university-based hospitals.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
